Boobies for Sale?

Tatas, "second base", Hooters, Boobs, Boobies, Jugs, etc... - you've all heard them - those familiar slang terms referring to our female breasts. Many breast cancer organizations now use these words in their company names, campaigns or fundraising. There is no question that catchy references to our feminine parts attracts attention. BUT - is using sexualizing slang terms for our breasts the right approach for raising awareness of breast cancer? Is promoting awareness with "I (heart) boobies" and the accompanying controversy helping or hurting our cause? Does watching men parade around in bras for charity events really send the right message? Or has the "branding" of breast cancer awareness gone just a bit astray in its messages? We live in an age of viral messaging, so these campaigns can develop a life of their own, gaining a whole lot of attention along the way. But is it the right attention?

Clearly, the answer to these questions is very personal. For some, if it results in more funding for breast cancer research or services, then the end outcome is what really counts. Some women consider the sexual portrayal and terminology as humorous means of lightening the emotional toll of a breast cancer diagnosis. Others may take issue with the sexualization and objectification of their breasts in the name of raising awareness about or funds targeting a disease that has or could rob them of those breasts or their life.

Breast Cancer has been a part of my family for 3 generations. We carry the BRCA2 gene and are all about the cure! Speaking only for myself, I am not always comfortable when men pose in bras in the name of a breast cancer cure or fundraising. It's not that I am questioning the motive or sincerity of the "bra wearer", it's just that some of these displays in the name of cancer seem off-kilter. When I see high-fashion models with barely pubescent bodies parade runways in luxury bras in the name of breast cancer awareness, I wonder what is next. We definitely need all the support we can get and I get it, boobies sell. I just feel that breast cancer awareness has taken some wrong turns.

What's your take? Do you agree with increasing awareness by any means necessary? If so, how do you think these sexualized message campaigns are helpful to we women at risk of or surviving breast cancer? Do you think these messages or campaigns are getting the job done? Could we possibly Viva La Cure with self-respect?

Susan Beausang, 4Women.com

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap